Showing results (101-110 of 107) with videos related to
Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
The Journal of Experimental Medicine|December 9, 2015
Hif-1α and Hif-2α synergize to suppress AML development but are dispensable for disease maintenanceMilica Vukovic, Amelie V Guitart, Catarina Sepulveda, et al.EMBO Molecular Medicine|March 6, 2020
Follistatin is a novel therapeutic target and biomarker in FLT3/ITD acute myeloid leukemiaBai-Liang He, Ning Yang, Cheuk Him Man, et al.Blood|June 25, 2025
Transposable elements as novel therapeutic targets for PARPi-induced synthetic lethality in PcG-mutated blood cancerBernd Zeisig, Chiou-Tsun Tsai, Clemence Virely, et al.Blood|September 22, 2023
Inhibition of PLK4 remodels histone methylation and activates the immune response via the cGAS-STING pathway in TP53-mutated AMLCheuk-Him Man, Wing Lam, Chee-Chean Dang, et al.Science Translational Medicine|October 7, 2016
Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemiaStephen S Y Lam, Eric S K Ho, Bai-Liang He, et al.Nature Cancer|April 18, 2024
The selective prolyl hydroxylase inhibitor IOX5 stabilizes HIF-1α and compromises development and progression of acute myeloid leukemiaHannah Lawson, James P Holt-Martyn, Vilma Dembitz, et al.The Journal of Experimental Medicine|February 17, 2017
Fumarate hydratase is a critical metabolic regulator of hematopoietic stem cell functionsAmelie V Guitart, Theano I Panagopoulou, Arnaud Villacreces, et al.Pageof 11